Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Photocure ASA ( (PHCUF) ) has provided an update.
Photocure ASA has granted 348,000 share options to its employees, constituting approximately 1.28% of the total shares issued, as part of its long-term incentive program. This move, which includes options for key executives, aims to align employee interests with company growth, while also resetting the vesting period for certain options, potentially enhancing stakeholder value.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in delivering transformative solutions for bladder cancer patients. Their unique technology enhances cancer detection by making cancer cells glow bright pink, improving health outcomes globally. The company is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange.
YTD Price Performance: -4.35%
Average Trading Volume: 49,559
Current Market Cap: NOK1.61B
For a thorough assessment of PHCUF stock, go to TipRanks’ Stock Analysis page.